Navigating the Medicare "Shift" of 2026: What Your Prescription Costs Really Mean This Year
As we head into March, many Medicare beneficiaries are feeling the "sticker shock" of the new plan year. While the headlines focus on the historic $2,100 out-of-pocket cap, the reality on the ground is a bit more complex.
If you’ve noticed your pharmacy bill looks different—or that your 90-day supply is suddenly restricted—you aren't alone. Here is a breakdown of what we are seeing in 2026 and how to manage the changes.
1. The "Tier Shift": Why You Have a Deductible Now
For years, many plans offered "Tier 1" and "Tier 2" drugs (mostly generics) with no deductible. In 2026, we are seeing a significant "Tier Shift."
The Trend: To offset the costs of the new $2,100 spending cap, many insurance companies have moved drugs to higher tiers or applied the Standard Part D Deductible (up to $615) to drugs that used to be exempt.
The Result: You might pay the full "contracted price" for your medications in January, February, and March until that deductible is met, even if those same drugs only cost you a $5 copay last year.
Workaround: Ask your doctor if there is a Tier 1 alternative. Often, a drug on Tier 3 has a nearly identical generic on Tier 1 that may still be exempt from the deductible.
2. The 90-Day Supply "Squeeze"
One of the most frustrating changes this year involves maintenance medications. We are seeing a rise in "Non-Extended Day Supply" restrictions.
What’s Happening: Certain brand-name drugs that were previously available in 90-day mail-order or retail supplies are now restricted to 30-day fills only.
Why? Plans are using "utilization management" to monitor high-cost drugs more closely. This requires you to visit the pharmacy or wait for a delivery every single month.
Example: A popular blood thinner or diabetic medication that you used to get once a quarter now requires 12 trips to the pharmacy a year instead of four.
Workaround: If monthly trips are a burden, check if your plan has a Preferred Mail Order pharmacy. While the supply might still be 30 days, having it show up at your door automatically can mitigate the hassle.
3. Negotiated Prices vs. Plan Formularies
2026 is the first year that Medicare Negotiated Prices for the "Initial 10" drugs (like Eliquis, Jardiance, and Enbrel) are in effect.
The Detail: While the price of the drug is lower for the Medicare program, your cost-sharing depends on your plan’s specific tiering. Some plans have moved these negotiated drugs to "Non-Preferred" tiers to discourage their use in favor of other rebates.
Example: You might expect a "negotiated" drug to be cheap, but if your plan put it on Tier 4, you could still be paying coinsurance (a percentage) rather than a flat copay.
How to Fight Back: 3 Strategies for March
Utilize the "Medicare Prescription Payment Plan": This is a new-for-2026 feature. Instead of paying a $600 deductible all at once in March, you can opt into a "smoothing" plan that spreads your out-of-pocket costs into monthly installments throughout the rest of the year.
Request a "Formulary Exception": If your brand-name drug was removed from the 90-day list or moved to a higher tier, your doctor can file an exception with the insurance company. If they can prove that the lower-tier alternatives are medically inappropriate for you, the plan may lower your cost.
The "GoodRx" Double Check: Sometimes, the "cash price" using a discount card is actually lower than your Medicare copay—especially if you are still stuck in the deductible phase. Note: Using these cards does not count toward your $2,100 Medicare cap.
Comments
Post a Comment